Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Trials
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Recent Studies (post-2010)
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
2198439,156187552

Protein Interaction Comparison

ProteinTaxonomydipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffman, DR; Johnston, JM; Moya, FR; Zhao, B1

Other Studies

1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Platelet-activating factor in surfactant preparations.
    Lancet (London, England), 1993, Apr-03, Volume: 341, Issue:8849

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipases A; Phospholipids; Phosphorylcholine; Platelet Activating Factor; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea

1993
chemdatabank.com